Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study

Boris Jung, Thomas Rimmele, Charlotte Le Goff, Gérald Chanques, Philippe Corne, Olivier Jonquet, Laurent Muller, Jean-Yves Lefrant, Christophe Guervilly, Laurent Papazian, Bernard Allaouchiche, Samir Jaber, AzuRea Group, Boris Jung, Thomas Rimmele, Charlotte Le Goff, Gérald Chanques, Philippe Corne, Olivier Jonquet, Laurent Muller, Jean-Yves Lefrant, Christophe Guervilly, Laurent Papazian, Bernard Allaouchiche, Samir Jaber, AzuRea Group

Abstract

Introduction: In this study, we sought describe the incidence and outcomes of severe metabolic or mixed acidemia in critically ill patients as well as the use of sodium bicarbonate therapy to treat these illnesses.

Methods: We conducted a prospective, observational, multiple-center study. Consecutive patients who presented with severe acidemia, defined herein as plasma pH below 7.20, were screened. The incidence, sodium bicarbonate prescription and outcomes of either metabolic or mixed severe acidemia were analyzed.

Results: Among 2, 550 critically ill patients, 200 (8%) presented with severe acidemia, and 155 (6% of the total admissions) met the inclusion criteria. Almost all patients needed mechanical ventilation and vasopressors during their ICU stay, and 20% of them required renal replacement therapy within the first 24 hours of their ICU stay. Severe metabolic or mixed acidemia was associated with a mortality rate of 57% in the ICU. Delay of acidemia recovery as opposed to initial pH value was associated with increased mortality in the ICU. The type of acidemia did not influence the decision to administer sodium bicarbonate.

Conclusions: The incidence of severe metabolic or mixed acidemia in critically ill patients was 6% in the present study, and it was associated with a 57% mortality rate in the ICU. In contradistinction with the initial acid-base parameters, the rapidity of acidemia recovery was an independent risk factor for mortality. Sodium bicarbonate prescription was very heterogeneous between ICUs. Further studies assessing specific treatments may be of interest in this population.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
General features of acid-base metabolism evaluated during the first three days. (A) pH. (B) Bicarbonatemia. (C) PaCO2. (D) Chloremia. (E) Lactatemia. (F) Corrected anion gap. *P < 0.05, Tukey's post hoc analysis between survivors (n = 66) and nonsurvivors (n = 89). #P < 0.05, Tukey's post hoc analysis vs day 0. Bars represent standard deviations. NS = not significant. PaCO2 = partial pressure of carbon dioxide.

References

    1. Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med. 2000;162:2246–2251.
    1. Kellum JA. Acid-base disorders and strong ion gap. Contrib Nephrol. 2007;156:158–166.
    1. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6:274–285. doi: 10.1038/nrneph.2010.33.
    1. Kaplan LJ, Cheung NH, Maerz L, Lui F, Schuster K, Luckianow G, Davis K. A physicochemical approach to acid-base balance in critically ill trauma patients minimizes errors and reduces inappropriate plasma volume expansion. J Trauma. 2009;66:1045–1051. doi: 10.1097/TA.0b013e31819a04be.
    1. Noritomi DT, Soriano FG, Kellum JA, Cappi SB, Biselli PJ, Liborio AB, Park M. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med. 2009;37:2733–2739. doi: 10.1097/CCM.0b013e3181a59165.
    1. Adrogue HJ, Gennari FJ, Galla JH, Madias NE. Assessing acid-base disorders. Kidney Int. 2009;76:1239–1247. doi: 10.1038/ki.2009.359.
    1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17–60. doi: 10.1007/s00134-007-0934-2.
    1. Kraut JA, Kurtz I. Use of base in the treatment of acute severe organic acidosis by nephrologists and critical care physicians: results of an online survey. Clin Exp Nephrol. 2006;10:111–117. doi: 10.1007/s10157-006-0408-9.
    1. Jaber S, Jung B, Sebbane M, Ramonatxo M, Capdevila X, Mercier J, Eledjam JJ, Matecki S. Alteration of the piglet diaphragm contractility in vivo and its recovery after acute hypercapnia. Anesthesiology. 2008;108:651–658. doi: 10.1097/ALN.0b013e31816725a6.
    1. Arieff AI, Gertz EW, Park R, Leach W, Lazarowitz VC. Lactic acidosis and the cardiovascular system in the dog. Clin Sci (Lond) 1983;64:573–580.
    1. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders: first of two parts. N Engl J Med. 1998;338:26–34. doi: 10.1056/NEJM199801013380106.
    1. Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10:R22. doi: 10.1186/cc3987.
    1. Tuhay G, Pein MC, Masevicius FD, Kutscherauer DO, Dubin A. Severe hyperlactatemia with normal base excess: a quantitative analysis using conventional and Stewart approaches. Crit Care. 2008;12:R66. doi: 10.1186/cc6896.
    1. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990;112:492–498.
    1. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med. 1991;19:1352–1356. doi: 10.1097/00003246-199111000-00008.
    1. Kellum JA. Disorders of acid-base balance. Crit Care Med. 2007;35:2630–2636. doi: 10.1097/01.CCM.0000286399.21008.64.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457. doi: 10.1016/S0140-6736(07)61602-X.
    1. Dubin A, Menises MM, Masevicius FD, Moseinco MC, Kutscherauer DO, Ventrice E, Laffaire E, Estenssoro E. Comparison of three different methods of evaluation of metabolic acid-base disorders. Crit Care Med. 2007;35:1264–1270. doi: 10.1097/01.CCM.0000259536.11943.90.
    1. Kellum JA. Clinical review: reunification of acid-base physiology. Crit Care. 2005;9:500–507. doi: 10.1186/cc3789.
    1. Boord JB, Graber AL, Christman JW, Powers AC. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med. 2001;164:1763–1767.
    1. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963. doi: 10.1001/jama.270.24.2957.
    1. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793–1800. doi: 10.1097/00003246-199811000-00016.
    1. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol. 1983;61:1444–1461. doi: 10.1139/y83-207.
    1. Kurtz I, Kraut J, Ornekian V, Nguyen MK. Acid-base analysis: a critique of the Stewart and bicarbonate-centered approaches. Am J Physiol Renal Physiol. 2008;294:F1009–F1031. doi: 10.1152/ajprenal.00475.2007.
    1. Smith I, Kumar P, Molloy S, Rhodes A, Newman PJ, Grounds RM, Bennett ED. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med. 2001;27:74–83. doi: 10.1007/s001340051352.
    1. Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med. 1987;106:615–618.
    1. Narins RG, Emmett M. Simple and mixed acid-base disorders: a practical approach. Medicine (Baltimore) 1980;59:161–187.
    1. Gunnerson KJ, Kellum JA. Acid-base and electrolyte analysis in critically ill patients: are we ready for the new millennium? Curr Opin Crit Care. 2003;9:468–473. doi: 10.1097/00075198-200312000-00002.
    1. Sabatini S, Kurtzman NA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol. 2009;20:692–695. doi: 10.1681/ASN.2007121329.
    1. Boyd JH, Walley KR. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care. 2008;14:379–383. doi: 10.1097/MCC.0b013e3283069d5c.
    1. Nichol AD, O'Cronin DF, Howell K, Naughton F, O'Brien S, Boylan J, O'Connor C, O'Toole D, Laffey JG, McLoughlin P. Infection-induced lung injury is worsened after renal buffering of hypercapnic acidosis. Crit Care Med. 2009;37:2953–2961. doi: 10.1097/CCM.0b013e3181b028ce.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅